RxDoctor Payments Data

Angela Messina, MD

Obstetrics & Gynecology · Clinton Twp, MINPI 1093805327

Payments from drug & device makers

$1,541in general payments, 2019–2025

Across 67 payments — averaging $23.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$341
  • Medtronic$285
  • Astellas Pharma US Inc$170
  • Acera Surgical, Inc.$148
  • Exact Sciences$63
  • Aspira Women's Health Inc$57
  • plus $478 from 19 others

What the payments were for

  • Food & beverage$1,52399%
  • Education$181%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,541 in reported general payments places this provider in the 70th percentile of 1,474 obstetrics & gynecology providers in Michigan.

See all obstetrics & gynecology providers in Michigan

Medicare billing

Part B allowed, 2024
$49,845
Medicare patients
150
Services billed
815

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol113$15,952
Estradiol (Twice Weekly)Estradiol60$8,645
SynthroidLevothyroxine Sodium54$6,248
ProgesteroneProgesterone, Micronized52$4,484
YuvafemEstradiol32$4,088
DottiEstradiol20$2,676
LyllanaEstradiol12$2,049
Nystatin-TriamcinoloneNystatin/Triamcinolone Acet30$1,339
ValacyclovirValacyclovir Hcl20$970
Ibandronate Sodium25$916
Levothyroxine Sodium28$353
Raloxifene Hcl12$331
Clobetasol Propionate11$306
Fluconazole19$280
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$197

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$341$6,24854 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$31$35328 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 1,474 obstetrics & gynecology providers in Michigan.

Other obstetrics & gynecology in Clinton Twp

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →